Koers Immune Pharmaceuticals Inc Nasdaq
Aandelen
US45254C2008
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 37 | 12-04-21 | |
Devin J. Shaw
DFI | Director of Finance/CFO | 37 | 13-04-21 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 11-12-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | - |
Tony Fiorino
BRD | Director/Board Member | 56 | 15-08-17 |
John A. Neczesny
BRD | Director/Board Member | 60 | 02-02-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+57,48% | 823 mld. | |
-7,18% | 353 mld. | |
+15,37% | 320 mld. | |
+7,45% | 295 mld. | |
+13,62% | 239 mld. | |
+14,55% | 220 mld. | |
-0,33% | 219 mld. | |
+8,14% | 167 mld. | |
-2,99% | 159 mld. |